Patients with Taylor's type focal cortical dysplasia (FCD) present with seizures that are often medically intractable. Here, we attempted to identify the cellular and pharmacological mechanisms responsible for this epileptogenic state by using ®eld potential and K + -selective recordings in neocortical slices obtained from epileptic patients with FCD and, for purposes of comparison, with mesial temporal lobe epilepsy (MTLE), an epileptic disorder that, at least in the neocortex, is not characterized by any obvious structural aberration of neuronal networks. Spontaneous epileptiform activity was induced in vitro by applying 4-aminopyridine (4AP)-containing medium. Under these conditions, we could identify in FCD slices a close temporal relationship between ictal activity onset and the occurrence of slow interictal-like events that were mainly contributed by GABA A receptor activation. We also found that in FCD slices, pharmacological procedures capable of decreasing or increasing GABA A receptor function abolished or potentiated ictal discharges, respectively. In addition, the initiation of ictal events in FCD tissue coincided with the occurrence of GABA A receptordependent interictal events leading to [K + ] o elevations that were larger than those seen during the interictal period. Finally, by testing the effects induced by baclofen on epileptiform events generated by FCD and MTLE slices, we discovered that the function of GABA B receptors (presumably located at presynaptic inhibitory terminals) was markedly decreased in FCD tissue. Thus, epileptiform synchronization leading to in vitro ictal activity in the human FCD tissue is initiated by a synchronizing mechanism that paradoxically relies on GABA A receptor activation causing sizeable increases in [K + ] o . This mechanism may be facilitated by the decreased ability of GABA B receptors to control GABA release from interneuron terminals.
Summary
Patients with Taylor's type focal cortical dysplasia (FCD) present with seizures that are often medically intractable. Here, we attempted to identify the cellular and pharmacological mechanisms responsible for this epileptogenic state by using ®eld potential and K + -selective recordings in neocortical slices obtained from epileptic patients with FCD and, for purposes of comparison, with mesial temporal lobe epilepsy (MTLE), an epileptic disorder that, at least in the neocortex, is not characterized by any obvious structural aberration of neuronal networks. Spontaneous epileptiform activity was induced in vitro by applying 4-aminopyridine (4AP)-containing medium. Under these conditions, we could identify in FCD slices a close temporal relationship between ictal activity onset and the occurrence of slow interictal-like events that were mainly contributed by GABA A receptor activation. We also found that in FCD slices, pharmacological procedures capable of decreasing or increasing GABA A receptor function abolished or potentiated ictal discharges, respectively. In addition, the initiation of ictal events in FCD tissue coincided with the occurrence of GABA A receptordependent interictal events leading to [K + ] o elevations that were larger than those seen during the interictal period. Finally, by testing the effects induced by baclofen on epileptiform events generated by FCD and MTLE slices, we discovered that the function of GABA B receptors (presumably located at presynaptic inhibitory terminals) was markedly decreased in FCD tissue. Thus, epileptiform synchronization leading to in vitro ictal activity in the human FCD tissue is initiated by a synchronizing mechanism that paradoxically relies on GABA A receptor activation causing sizeable increases in [K + ] o . This mechanism may be facilitated by the decreased ability of GABA B receptors to control GABA release from interneuron terminals.
Introduction
Taylor's type focal cortical dysplasia (FCD) corresponds to a localized disruption of the normal cortical lamination with an excess of large, dysmorphic neurons (Taylor et al., 1971) . cryptogenic (Bronen et al., 1997; Guerrini et al., 1999; Bernasconi et al., 2001; Tassi et al., 2001 Tassi et al., , 2002 . Seizures in FCD patients are often medically intractable, which makes them candidates for neurosurgical interventions aimed at resecting the epileptogenic area that in most cases overlaps with the FCD tissue.
There exist several animal models of cortical dysgenesis (Baraban and Schwartzkroin, 1996; Jacobs et al., 1996; Luhmann and Raabe, 1996; Castro et al., 2001; Roper et al., 1997; Luhmann et al., 1998; DeFazio and Hablitz, 2000; Benardete and Kriegstein, 2002; Gabel and Lo Turco, 2002; Aronica and Gorter, 2003; Hagemann et al., 2003) . However, none of them successfully replicate Taylor's type FCD. To circumvent this problem, we have used in the past few years surgically resected human FCD tissue to identify the histochemical and functional characteristics of FCD neuronal networks. These studies have revealed that human FCD tissue has an abnormal distribution of N-methyl-D-aspartate (NMDA) receptors and a decreased number of presumptive interneurons that, however, provide increased GABAergic innervation to principal cells (Sprea®co et al., 1998) . Later, these ®ndings were con®rmed in other studies (Garbelli et al., 1999; Tassi et al., 2001 Tassi et al., , 2002 . In addition, by employing electrophysiological recordings in an in vitro slice preparation, we have found that FCD tissue, when treated with 4-aminopyridine (4AP), generates NMDA receptor-mediated ictal discharges along with isolated, interictal-like synchronous potentials that are contributed by GABA receptormediated along with glutamatergic mechanisms (Mattia et al., 1995; Avoli et al., 1999) . Comparative studies performed with a similar 4AP treatment in human neocortical tissue presenting with no obvious structural abnormality have revealed that these slices can only generate periodic, synchronous, interictal-like events that are also due, to a large extent, to GABA receptor-mediated conductances (Avoli et al., 1994) .
During 4AP treatment, the onset of ictal discharges in rodent entorhinal cortex (Avoli et al., 1996a; Lopantsev and Avoli, 1998; Barbarosie et al., 2002) or in immature rat hippocampal slices (Avoli et al., 1993 (Avoli et al., , 1996b ) is often associated with GABA receptor-mediated potentials resembling those seen in human FCD slices. Moreover, this mechanism probably relies on transient increases in [K + ] o that accompany the GABA receptor-mediated events. Here, we attempted to identify in human FCD tissue a similar causative relationship between GABA receptor-mediated synchronization and ictogenesis. In particular, we used ®eld potential and K + -selective recordings in neocortical slices obtained during surgery for medically intractable seizures associated with FCD and, for purposes of comparison, from patients with mesial temporal lobe epilepsy (MTLE); this type of neocortex does not show any obvious structural aberration, including abnormal lamination (Avoli et al., 1991 (Avoli et al., , 1994 Sprea®co et al., 1998; Louvel et al., 2001) . Slices were superfused with 4AP-containing medium to increase neuronal excitability, and thus to elicit spontaneous epileptiform activity in vitro.
Speci®cally, we tested four hypotheses. First, we postulated that ictal discharge onset in FCD slices should be associated with ®eld potential activity sharing electrographic and pharmacological properties that are typical of 4AP-induced GABA receptor-mediated synchronization. Secondly, we anticipated that if GABA receptor-mediated synchronization is necessary for ictogenesis, then ictal discharges should disappear or increase during pharmacological procedures that antagonize or enhance GABA receptor-mediated mechanisms, respectively. Thirdly, we presumed that GABA receptor-mediated events associated with ictal activity onset should be accompanied by [K + ] o elevations that are larger than those seen during the interictal period. Finally, we expected that during application of 4AP and glutamatergic receptor antagonists (a procedure that abolishes epileptiform activity, but only reduces the duration of the GABA receptor-mediated potentials), GABA receptordependent [K + ] o increases should be larger in FCD than in MTLE cortical slices.
Methods
Neocortical samples were obtained during neurosurgery for medically intractable seizures associated with MTLE (n = 7 patients aged 26±40 years) and with FCD (n = 11 patients aged 9±38 years). The tissue samples used for the in vitro electrophysiologial investigations were always part of a block of brain tissue removed for strict therapeutic reasons. Informed consent was obtained according to the guidelines of the ethics committees of our institutions which approved the study. All patients have been maintained on a variety of antiepileptic drugs that were discontinued or reduced during the weeks preceding surgery. Surgery was carried out under general anaesthesia with halogenated compounds. During the resecting procedure, care was taken by the neurosurgeon to provide cortical samples that contained the FCD tissue. Neuropathological analysis of the removed brain tissue revealed in MTLE patients a mild to moderate degree of gliosis, while cortical lamination was always preserved. In contrast, structural disruption along with the presence of large, aberrant neurons was seen in the tissue obtained from FCD patients (see Sprea®co et al., 1998) . Table 1 summarizes the MRI and neurophysiological ®ndings obtained in FCD patients.
Preparation and maintenance of the slices
Details on the techniques used to prepare and to maintain the slices in vitro have been described in previous studies from our laboratories (Avoli et al., 1994 Louvel et al., 2001) . In brief, neocortical slices (500 mm thick) were cut with a McIlwain tissue chopper and were transferred to a recording chamber where they were maintained at 33.0 T 1.0°C at an interface between humidi®ed gas (95% O 2 ±5% CO 2 ) and oxygenated arti®cial cerebrospinal¯uid (ACSF; pH = 7.4). Efforts were made to minimize the time elapsed between surgical resection and slicing (usually <5 min). ACSF composition was (in mM): 124 NaCl, 2 KCl, 2 MgSO 4 , 2 CaCl 2 , 1.25 KH 2 PO 4 , 26 NaHCO 3 and 10 glucose. The following drugs were bath applied: 4AP (50 mM, Sigma), 4-amino-3-[4-chloro-phenyl]-butanoic acid (baclofen; 2±50 mM, Sigma), 3-(2-carboxy-piperazine-4-yl)-propyl-l-phosphonate (CPP; 20 mM, Tocris Cookson), 6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX; 10±20 mM, Tocris Cookson), bicuculline methiodide (BMI; 20 mM, Sigma), picrotoxin (50 mM, Sigma), (D-Ala2-N-Me-Phe,Glyol)enkephalin (DAGO; 10 mM, Sigma), naloxone (5 mM, Sigma), phenobarbital (20±100 mM, Sigma) and P3-amino-propyl-Pdiethoxymethyl-phosphonic acid (CGP 35348; 1 mM, kindly donated by Novartis, Basel, Switzerland).
Electrophysiological recordings
Field potential recordings were obtained with pipettes ®lled with ACSF. Field potentials were also recorded through the reference channel of the ion-selective electrodes. Signals were fed to DC highimpedance ampli®ers with ®lters that were usually set to record between DC and 1 kHz. Measurements of [K + ] o were obtained by using double-barrelled ion-selective electrodes (tip diameters = 2± 4 mm) based on the valinomycin ion exchanger Fluka 60398. The reference channel was back®lled with 150 mM NaCl and the ionselective channel with 100 mM KCl. Details concerning the [K + ] o measurements can be found in our previous publications Louvel et al., 2001 ). Signals were displayed on an oscilloscope and on a Gould pen recorder. In some experiments, ®eld potential and [K + ] o recordings were also stored on a personal computer through a 1401 interface (C.E.D., Cambridge, UK).
Statistical analysis
Measurements were made and averaged over periods longer than 10 consecutive minutes and are expressed as mean T SEM, while n indicates the number of slices analysed. Statistical comparisons were made with one-way analysis of variance (ANOVA), and differences were considered signi®cant if P < 0.05.
Results

Field potential and [K + ] o recordings during 4-aminopyridine application
The ability of 4AP treatment to disclose patterns of synchronous activity that differ in human cortical tissue obtained from MTLE or FCD patients has already been reported by us (Avoli et al., 1994 Mattia et al., 1995; Louvel et al., 2001) . Here, we con®rmed that bath application of 4AP to MTLE slices (n = 21) induced spontaneous, monophasic negative or biphasic negative±positive ®eld potentials (amplitude = 0.3±4 mV; intervals of occurrence = 4± 19 s) that were associated with transient elevations in [K + ] o with peak values up to 4.3 mM (3.8 T 0.3 mM, n = 46 events) from a baseline of 3.2 mM (Fig. 1A) . When this 4AP-induced activity was recorded at different depths along an axis normal to the pial surface, we found that the synchronous ®eld potentials had maximal negative amplitude at depths of 1100±1400 mm (not shown; but see Avoli et al., 1994) . Similar ®eld potential events and [K + ] o elevations were induced by extracellular focal electrical stimuli (Fig. 1A , ®lled triangle). Ictal discharges (de®ned as synchronous ®eld potential activity organized in a continuous pattern with duration >4 s) were never seen in MTLE slices treated with 4AP.
In contrast, bath application of 4AP to FCD slices (n = 22 out of 39 from 11 patients) caused the appearance of (i) ictal discharges that lasted up to 130 s and recurred at intervals of 1±8 min; and (ii) isolated ®eld potentials that were similar to those recorded in MTLE slices (lines and asterisks in Fig. 1B , a and c, respectively). Only slow interictal activity could be recorded in 17 FCD slices. As reported in previous studies (Mattia et al., 1995; Avoli et al., 1999) , ictal discharges were characterized by prolonged negative shifts with superimposed oscillations with frequencies up to 25 Hz (presumably representing synchronous action potential ®ring). As shown in the two experiments of Fig. 1B , ictal discharge onset was associated with the occurrence of a negative ®eld potential that resembled those recorded in isolation during the interictal period, but was of larger amplitude (Fig. 1B , a and c, arrow) and often followed by a slow (duration up to 2.5 s; arrowhead in Fig. 1B , a and c) negative event from which the ictal discharge initiated. The different amplitude and shape characteristic of the negative ®eld events occurring in isolation and at ictal discharge onset are illustrated in detail in Fig. 1B , b (panels 1 and 2, respectively). The temporal Note that in both cases, the activity is characterized by isolated interictal ®eld potentials (asterisks) and sustained epileptiform events resembling ictal discharges (continuous lines). Note also that the onset of the ictal event is associated with the occurrence of a negative ®eld potential (arrow) followed by a slow negative event (arrowhead) leading to ictal discharge oscillations. The different characteristics of the isolated negative ®eld events (1) and of the ictal discharge onset (2) are shown in b for 3±4 graphically superimposed samples obtained from the experiment in a; note that the isolated interictal events are of lower amplitude compared with those leading to ictogenesis. (C) Temporal relationship between the occurrence of slow interictal events and ictal discharge onset during 4AP application.
In a is shown a histogram of the probability of occurrence of the interictal activity over a period of 50 s before the ictal onset normalized to an epoch 5 s prior to the ictal event; data were obtained from 64 epochs that were recorded in 11 FCD slices. One of these epochs (recorded with a high-pass ®ltered set at 0.1 Hz) is shown in b. The arrow highlights the time 0, while the asterisks point at the slow interictal events.
relationship between slow interictal events and ictal discharges is shown further in the histogram of Fig. 1C , where the probability of occurrence of the interictal activity over a 50 s period before ictal onset was obtained from 64 epochs recorded in 11 FCD slices. Simultaneous recordings performed with ®eld potential and K + -selective electrodes in 11 FCD slices obtained from three patients demonstrated that the isolated negative-going events were associated with transient elevations in [K + ] o that reached peak values~5.0 mM from a baseline of~3.2 mM ( Fig. 2A, asterisk) . In contrast, the negative-going events occurring at the onset of the ictal discharge were accompanied by [K + ] o increases up to 8 mM ( Fig. 2A, small arrow) . The histogram of Fig. 2B summarizes the peak values of the [K + ] o elevations associated with the slow negative ®eld potentials occurring in isolation between ictal discharges and with the negative event occurring shortly before ictal discharge onset.
[K + ] o recorded during the ictal event reached values in excess of 12 mM; these elevations in [K + ] o were maximal throughout the initial`tonic' phase of the discharge, and slowly recovered to baseline levels during the`clonic' phase. Small (<500 mm) displacements of the recording electrodes along either the vertical or horizontal axis of the FCD slice could cause conspicuous changes in the characteristics of the ®eld potentials and of the [K + ] o elevations induced by 4AP application (control panels in Fig. 7A ).
GABA A receptor function modulates 4-aminopyridine-induced ictal discharges in FCD slices
Application of the GABA A receptor antagonist BMI (n = 6) abolished the slow negative ®eld events along associated with the isolated negative-going events (n = 44 events from ®ve slices), those occurring during the negative-going events preceding ictal discharge (n = 12 events from three slices) and during the ongoing ictal activity (identi®ed as ictal peak; n = 12 events from three slices); single and double asterisks indicate statistical signi®cance of P < 0.05 and P < 0.02, respectively. with ictal discharges induced by 4AP, and disclosed a pattern of short-lasting (<1 s) recurrent epileptiform bursting (Fig. 3A) . The activity recorded during application of 4AP + BMI was reversibly reduced in duration by the NMDA receptor antagonist CPP (n = 3) (Fig. 3A) . Such a procedure abolished ictal synchronization in the presence of 4AP only (not shown; but see Avoli et al., 1999) . Ictal discharges were also blocked by applying the m-opioid receptor agonist DAGO (n = 3; Fig. 3B ). This pharmacological treatment is known to hyperpolarize interneurons and thus decreases GABA release from interneurons (Madison and Nicoll, 1988; Capogna et al., 1993) . DAGOinduced effects were characterized by a progressive reduction in both rate of occurrence and amplitude of the negative ®eld events (Fig. 3B, a, arrows) , and by the appearance of recurrent interictal bursting similar to that seen during BMI treatment. Thus, these experiments indicate that in FCD tissue, the generation of prolonged epileptiform events, resembling ictal discharges, depends on GABA A receptor function.
Next, we analysed the effects induced by enhancing GABA A receptor-mediated inhibition by applying phenobarbital. In FCD slices treated with 4AP-containing medium, low concentrations of phenobarbital (20 mM, n = 3/4) increased the duration and amplitude of both interictal and ictal discharges, while prolonging their interval of occurrence (Fig. 4A±C) . The effects of phenobarbital on the ictal event were often accompanied by an increase in the amplitude of the ®eld oscillations at~20 Hz that were seen at discharge onset (inserts in Fig. 4A ). Further increasing the phenobarbital dose to 40 mM abolished ictal activity in all experiments and reduced the duration and the rate of occurrence of the Fig. 3 The occurrence of ictal discharges induced by 4AP in FCD slices depends on the function of GABA A receptors. (A) Bath application of the GABA A receptor antagonist BMI (10 mM) transforms ictal activity into regular, interictal discharges and abolishes the isolated negative ®eld potentials. Further addition of the NMDA receptor antagonist CPP (10 mM) reduces the duration of most of the interictal discharges. Note in the expanded traces the occurrence of ®eld oscillations at~20 Hz during the afterdischarge that accompanies some of the interictal events recorded during concomitant application of 4AP + BMI + CPP. (B) Effects similar to those induced by BMI are obtained with the m-opioid receptor agonist DAGO (10 mM). Note that DAGO reduces the amplitude of the isolated negative ®eld events (arrows in sample a). Traces identi®ed as a and b represent a continuous recording that was started 2 min after the onset of DAGO application.
interictal events (Fig. 4A) . Finally, all activities disappeared with phenobarbital concentrations of 80 mM (not illustrated; but see plots in Fig. 4B and C) . Moreover, in two FCD slices that generated only isolated interictal activity in the presence of 4AP, 20 mM phenobarbital made ictal events appear (Fig. 4D) ; epileptiform activities in these experiments were also abolished by increasing the phenobarbital doses to 60 mM (not illustrated).
GABA B receptor activation abolishes 4-aminopyridine-induced epileptiform activity in FCD slices
Next, we tested the effects induced by the GABA B receptor agonist baclofen on the 4AP-induced ictal discharges generated by slices obtained from FCD tissue samples (n = 4). As illustrated in Fig. 5A , baclofen abolished the ictal events recorded in these slices at concentrations as low as 2 mM. However, isolated interictal events continued to occur under these experimental conditions (asterisks in Fig. 5A ). This type of activity disappeared during application of baclofen doses >40 mM (see below). The effects induced by baclofen on ictal discharges were fully reversed by additional application of the GABA B receptor antagonist CGP 35348 (1 mM) (Fig. 5A) .
We also analysed the effects induced by blocking (CGP 35348, 1 mM) or activating (baclofen, 10±50 mM) GABA B receptor function on the isolated interictal discharges that represented the only epileptiform activity generated by ®ve FCD slices during 4AP application. CGP 35348 reversibly increased interictal discharge duration by 30±65% (n = 3; Fig. 5B ), while baclofen depressed them in a dose-dependent manner (Fig. 5C±F) . GABA B receptor activation and pharmacologically isolated GABA receptor events in MTLE and FCD slices
We have reported that GABA B receptor activation reduces and eventually abolishes spontaneous GABA receptor-mediated ®eld potentials recorded in the presence of 4AP and excitatory amino acid receptor antagonists in human neocortical tissue with no structural abnormality (Louvel et al., 2001 ). Here, we further compared the effects induced by baclofen on these events in MTLE and FCD slices (n = 4 and 6, respectively). As illustrated in Fig. 6A and B, increasing concentrations of baclofen reduced the amplitude and the rate of occurrence of these presumptive GABA receptor-mediated events in both MTLE and FCD slices. However, the doses of baclofen required to exert similar depressant effects were consistently larger in FCD slices (P < 0.05 for the data obtained with baclofen doses higher than 10 mM). Accordingly, the normalized histograms of the baclofen effects suggested an extrapolated IC 50 of~20 and 40 mM in MTLE and FCD slices, respectively (Fig. 6C and D) . 
[K + ] o recordings during application of 4-aminopyridine and glutamatergic receptor antagonists
In keeping with early ®ndings obtained from human cortical slices with no structural abnormality (Louvel et al., 2001) , the synchronous isolated events recorded during application of 4AP + glutamatergic receptor antagonists (i.e. CNQX + CPP, 10 mM each) from MTLE slices (n = 21) were accompanied by small [K + ] o elevations (up to 4.0 mM from a background level of 3.2 mM) ( Fig. 7A and B) . We also con®rmed (see Louvel et al., 2001 ) that the [K + ] o increases recorded at different depths along an axis normal to the pial surface displayed a consistent pattern of distribution characterized by [K + ] o increases that were largest and fastest at depths of 1000 mm below the pial surface ( Fig. 7B and C) . This location should correspond to the middle layers, a site that includes the apical dendritic arborizations originating from pyramidal cells with somas localized in the deep layers. Moreover, this was the depth at which the negative ®eld potentials were of maximal amplitude.
Next, we analysed the increases in [K + ] o associated with the glutamatergic-independent synchronous events generated by FCD slices (n = 5). As shown in Fig. 7D , application of CNQX + CPP to slices pre-treated with 4AP abolished the ictal discharges and the concomitant [K + ] o elevations, while the isolated ®eld events continued to occur. It is also possible to appreciate in this experiment that under control conditions, both ®eld potentials and [K + ] o elevations associated with the ictal activity were markedly reduced by changing the position of the recording electrode along the horizontal axis of the FCD slice (cf. traces obtained from sites 2 and 6 in Fig. 7D,  control) . Interestingly, the sites in the slices from which ictal discharges had larger amplitude under control conditions were also those displaying the largest ®eld potentials and [K + ] o elevations during the presumptive GABA receptormediated event recorded during blockade of glutamatergic transmission (Fig. 7D , + CNQX + CPP). Therefore, in contrast to what was observed in MTLE slices, the distribution of the [K + ] o increases (and of the ®eld potential amplitude) in FCD slices superfused with 4AP + CNQX + CPP Fig. 6 Effects induced by the GABA B receptor agonist baclofen on the isolated ®eld potentials recorded in MTLE (A) and FCD (B) slices superfused with medium containing 4AP and glutamatergic receptor antagonists (CNQX + CPP). Note that in both experiments, GABA B receptor activation reduces and eventually abolishes these presumptive GABA receptor-mediated ®eld potentials. However, the depressant effects of baclofen are characterized by a higher threshold in the FCD slice. (C and D) Dose±response histograms of the effects induced by baclofen on the rate of occurrence and amplitude of the glutamatergic-independent events generated by MTLE (n = 4) and FCD (n = 5) slices during 4AP application. Note that doses of baclofen capable of reducing the isolated GABA receptor-mediated events by~50% are higher in the FCD slices (i.e.~40 mM) compared with the MTLE experiments (i.e.~20 mM). Data are normalized to control values obtained over a period of 10 min immediately prior to drug application.
was not restricted to any particular depth from the pia. For instance, as shown in the experiment of Fig. 7E , the largest [K + ] o increases were found at 1200 and 2400 mm (corresponding to positions 2 and 8, respectively). This is summarized for the four experiments performed under these conditions in the normalized histogram of Fig. 7E .
Discussion
The present ®ndings indicate that epileptiform synchronization leading to in vitro ictal activity in the human FCD tissue is initiated (and presumably maintained) by a synchronizing mechanism that paradoxically relies on the activation of GABA A receptors. This conclusion rests on: (i) the temporal relationship seen between the slow interictal-like events (which are mainly contributed by GABA A receptor activation) and ictal activity onset; and (ii) the evidence obtained by modifying GABA A receptor function through the use of pharmacological agents. We have also provided evidence that supports the potential role of GABA A receptor-dependent increases in [K + ] o in exerting such a pro-epileptogenic action in FCD tissue. Finally, we have found that this new mechanism may rely on a decreased function of GABA B receptors presumably located at the presynaptic inhibitory terminals. Temporal relationship between presumptive GABA receptor-mediated events and ictal discharge onset in FCD tissue
We have con®rmed here that 4AP application to neocortical slices obtained from FCD patients makes prolonged (socalled ictal) and short-lasting (termed interictal) epileptiform discharges appear . In contrast, only the latter type of activity was seen under similar experimental conditions in MTLE slices (which presumably did not present with any obvious structural abnormality) (Avoli et al., 1994; Louvel et al., 2001) . It is unlikely that this difference was due to the fact that our control tissue originated from the temporal cortex. In fact, no ictal discharges could be observed during 4AP application in non-FCD slices of frontal and occipital cortices (Avoli et al., 1994) . We have demonstrated previously that the ictal activity in FCD slices is abolished by NMDA receptor antagonists , while the interictal events recorded in both types of tissue are mostly contributed by GABA receptor-mediated conductances (Avoli et al., 1994 . Therefore, the present ®ndings support the view that epileptogenicity is a functional feature of FCD tissue; such a conclusion is in line with data obtained from animal models of cortical maldevelopment, even though associated with histopathological patterns that are dissimilar to Taylor's type FCD (Baraban and Schwartzkroin, 1996; Jacobs et al., 1996; Luhmann and Raabe, 1996; Castro et al., 2001; Roper et al., 1997; Luhmann et al., 1998; DeFazio and Hablitz, 2000; Benardete and Kriegstein, 2002; Gabel and Lo Turco, 2002; Aronica and Gorter, 2003; Hagemann et al., 2003) . It should be emphasized that the ictal activity induced by 4AP in FCD slices resembled the electrographic activity seen during pre-excision ECoG in these patients (Palmini et al., 1991 (Palmini et al., , 1995 Gambardella et al., 1996) , a pattern that is believed to be a speci®c and sensitive indicator of FCD lesions.
We have also identi®ed a close temporal relationship between ictal discharge onset and the occurrence of GABA receptor-mediated interictal events in FCD slices. Accordingly, ictal discharges recorded in the presence of 4AP were preceded shortly by negative-going events similar to those seen in isolation during the interictal period. However, the ®eld potentials leading to ictal discharge onset were always of larger amplitude and were often followed by a secondary, slow negative ®eld event from which ictal oscillations emerged. Studies performed in rodent brain slices have shown that 4AP application induces patterns of epileptiform activity that depend upon the type of cortical network. For instance, adult isolated hippocampal slices can only generate interictal-like discharges that include shortlasting, CA3-driven events and slow GABA receptor-mediated potentials (Perreault and Avoli, 1992) , while ictal discharges occur in adult entorhinal networks (Avoli et al., 1996a; Buchheim et al., 2000) . Moreover, the occurrence of ictal synchronization in isolated hippocampal slices treated with 4AP depends on the maturity of the tissue (Avoli et al., 1993 (Avoli et al., , 1996b , a characteristic that is mirrored by the higher propensity of young animals to generate seizures in vivo (Purpura, 1969; Cavalheiro et al., 1987; Moshe 1993) . Hence, one may speculate that the dysplastic cortex reverts to, or rather retains ontogenetically immature properties and is therefore susceptible to seizure generation in a way similar to the young rodent hippocampus. It should be emphasized that in these animal studies as well, ictal activity onset is characterized by the occurrence of GABA receptor-mediated events similar to those recorded in FCD tissue (Avoli et al., 1993 (Avoli et al., , 1996a . Hence, the ability of human FCD slices to generate ictal discharges, as compared with cortical MTLE tissue, may re¯ect the abnormal neuronal connectivity seen in this type of tissue (Sprea®co et al., 1998; Ko Èhling et al., 1999) .
Pharmacological manipulations of the GABA A receptor modulate ictal discharges in FCD slices
The involvement of GABA receptor-mediated synchronization in initiating ictal activity in FCD tissue is supported by pharmacological manipulations that were aimed at decreasing or enhancing the function of GABA (mainly type A) receptors. Accordingly, we have found that activation of mopioid receptors (a pharmacological procedure that blocks the release of GABA from interneuron terminals) (Capogna et al., 1993; Madison and Nicoll, 1988) or blockade of GABA A receptors abolished the ictal discharges induced by 4AP along with the GABA receptor-mediated interictal events; under both conditions, FCD slices only generated recurrent epileptiform activity at~0.3 Hz. A similar pattern of robust interictal discharge has been recorded in rodent brain slices during application of 4AP and GABA A receptor antagonists (Avoli et al., 1996a, b; Lopantsev and Avoli, 1998; Bruckner et al., 1999; Barbarosie et al., 2002) . It has been proposed that interictal bursts may have anti-seizure properties (Barbarosie and Avoli, 1997; Barbarosie et al., 2002) . Hence, we cannot exclude that the loss of 4AP-induced ictal activity seen in FCD slices during application of either BMI or DAGO was also contributed by such a mechanism.
Conversely, potentiating GABA A receptor function with minimal concentrations of phenobarbital (Nicoll et al., 1975; Barker and McBurney, 1979) caused ictal discharge prolongation along with potentiation of slow interictal events. Although both types of epileptiform activity were abolished by further increasing the concentration of this barbiturate, the facilitating action identi®ed with low doses supports the view that a GABA A receptor-mediated mechanism can lead to ictogenesis in FCD neuronal networks. A recent comparative study performed in isolated hippocampal slices obtained from rats treated with methylazoxymethanol in utero (which represents an experimental model of cortical dysplasia) and from control animals has shown that phenobarbital does not in¯uence 4AP-induced interictal activity in dysplastic tissue (Smyth et al., 2002) .
The paradoxical role played by GABA receptor-mediated mechanisms in initiating ictal activity was originally reported in the CA3 sub®eld of young (<30-day-old) rat slices treated with 4AP (Avoli et al., 1993 (Avoli et al., , 1996b and later con®rmed in adult rodent entorhinal cortex (Avoli et al., 1996a; Lopantsev and Avoli, 1998; Barbarosie et al., 2002) . It is worth emphasizing that intracellular recordings obtained from entorhinal cortex neurons during application of 4AP indicate that GABA A receptor-mediated conductances may also play a role in the maintenance of ictal synchronization (Lopantsev and Avoli, 1998) . GABA A receptor-mediated mechanisms also contribute to epileptiform afterdischarges induced in the hippocampus by tetanic stimulation (Higashima et al., 1996; Velazquez and Carlen, 1999) . Similar conclusions have been drawn by Ko Èhling et al. (2000) while analysing the mechanisms responsible for ictogenesis in hippocampal slices superfused with Mg 2+ -free medium.
The pro-convulsant effects exerted by GABA receptormediated mechanisms may rest on the entrainment of interneuronal network via GABAergic interactions (presumably, GABA A receptor-mediated depolarizing events) (Ko Èhling et al., 2000) along with increased axonal back®ring (which has been proposed to be under the control of presynaptic GABA receptors) (Stasheff et al., 1993) . However, the evidence obtained in rodent slices during 4AP application (Avoli et al., 1996a, b) or high-frequency stimulation (Smirnov et al., 1999) suggests that GABA receptor-dependent elevations in [K + ] o may play an even more relevant role (see below).
Elevations in [K + ] o and ictal discharge initiation
Our data indicate that GABA receptor-dependent [K + ] o homeostasis may contribute to the occurrence of ictal discharges in the human FCD tissue. First, we have found that the elevations in [K + ] o recorded in these slices during the slow 4AP-induced interictal events attained maximal values that were often larger than those accompanying a similar type of synchronous activity in MTLE slices. Secondly, the GABA receptor-mediated potentials that shortly preceded the ictal discharge onset were characterized by rises in [K + ] o that were larger than those seen in association with similar ®eld potentials occurring during the interictal period. We previously have reported an association of similar large elevations in [K + ] o and ictal discharge onset in the deep layers of the entorhinal cortex (Avoli et al., 1996a; Barbarosie et al., 2002) and in the CA3 stratum radiatum of isolated hippocampal slices obtained from young rats (Avoli et al., 1996b) . Data obtained in the latter study have revealed that the occurrence of ictal activity in the CA3 area is characterized by developmental changes in GABA receptor-dependent [K + ] o homeostasis. Indeed, elevating [K + ] o can disclose seizure activity both in vivo (Zuckermann and Glaser, 1968) and in vitro (Traynelis and Digledine, 1988; Traub and Dingledine, 1990) .
Several studies have shown that slow GABA receptormediated events induced by 4AP in hippocampal (Michelson and Wong, 1991; Perreault and Avoli, 1992; Staley et al., 1995; Lamsa and Kaila, 1997) , entorhinal (Avoli et al., 1996a) and neocortical networks (Avoli et al., 1994; Benardo, 1997) (Avoli et al., 1996a, b; Lamsa and Kaila, 1997) . These [K + ] o elevations, which are abolished by GABA A receptor antagonists, re¯ect depolarization of neurons and glia caused by the activation of GABA A receptors that may lead to outward counter/co-transport of K + due to the action of the K + /Cl ± exchanger KCC2, possibly in combination with a depolarizing action of GABA caused by Cl ± equilibrium and Cl ± /HCO 3 + anion shift (Kaila et al., 1993 Kaila, 1994; Staley et al., 1995; Avoli et al., 1996a, b; Rivera et al., 1999) .
We have con®rmed these ®ndings here by recording ®eld potential and [K + ] o in FCD and MTLE slices during application of 4AP and glutamatergic receptor antagonists. However, some important differences emerged when comparing the depth distribution and the size of the [K + ] o increases recorded in these two types of human cortical tissue. First, we could con®rm that the largest increases in [K + ] o in slices obtained from MTLE patients were localized between 600 and 1400 mm from the pia (see Louvel et al., 2001) , while in FCD slices the [K + ] o increases attained maximal values at depths that varied greatly from one experiment to another. The lack of a typical depth pro®le points to a severe disturbance of the neuronal network in dysplastic tissue. In agreement with this, the initiation foci for Mg 2+ -free-induced discharges appear to be heterogeneous and multilayered in FCD slices (Ko Èhling et al., 1999 (Sprea®co et al., 1998; Garbelli et al., 1999; Tassi et al., 2001 Tassi et al., , 2002 indicate that even though GABAergic cells are decreased in number, they provide an`overexpression' of GAD-positive terminals that surround large, dysmorphic glutamatergic neurons. Aasly et al. (1999) , by using proton magnetic resonance spectroscopy, have found an increase in GABA content in biopsies obtained from patients with cortical dysplasia.
GABA B receptor function in FCD and MTLE slices
We have found in FCD slices that application of baclofen at concentrations as low as 2 mM can abolish 4AP-induced ictal discharges, but not the interictal events (which are largely contributed by a GABA receptor-mediated mechanism); indeed, this latter activity disappeared only with baclofen concentrations >40 mM. Moreover, these baclofen effects were fully antagonized by CGP 35348, even though it has been reported that this antagonist may have weak effects on presynaptic GABA B receptors (Deisz, 1999) . Hence, we are inclined to conclude that the changes induced by baclofen were caused mainly by the activation of GABA B receptors that are known to be located both post-and presynaptically on principal (glutamatergic) cells and interneurons Nicoll, 1984, 1985; Misgeld et al., 1989; Thompson and Ga Èhwiler, 1992; Williams and Lacaille, 1992; Lambert and Wilson, 1993) . Our results also suggest that the relative resistance of the slow interictal activity to baclofen may re¯ect a downregulation of GABA B receptors within the interneuron network in the FCD tissue. Early studies have demonstrated that baclofen may depress excitatory transmitter release to a greater extent than GABA release (Pierau and Zimmermann, 1973; Potashner, 1978) .
To better identify the mechanisms underlying the resistance of the GABA receptor-dependent interictal events to baclofen, we also analysed the effects exerted by this GABA B receptor agonist on the synchronous activity recorded in FCD and MTLE slices during application of 4AP and glutamatergic receptor antagonists. The synchronous potentials recorded under these experimental conditions re¯ect the ®ring of interneurons leading to GABA release and to the consequent activation of postsynaptic GABA receptors. We have, indeed, found that the half-maximal doses of baclofen required to depress the glutamatergic-independent events (and thus to inhibit the release of GABA from interneuron terminals) in FCD and MTLE slices were signi®cantly higher in the former (i.e. 40 and 20 mM). Therefore, these ®ndings suggest that the function of GABA B receptors located on interneurons may be downregulated in FCD tissue. Interestingly, Uusisaari et al. (2002) have reported that epileptiform activity mediated by GABA A receptors and gap junctions occurs in rat hippocampal slices during prolonged application of GABA B receptor antagonists.
Conclusions
The results obtained in this study suggest that GABA receptor-mediated synchronization represents a mechanism for seizure initiation in the human FCD where it appears to be related to the ability of GABA to cause sizeable increases in [K + ] o . Moreover, the ®ndings obtained with baclofen show a decreased ability of this GABA B receptor agonist to control the release of GABA from interneuron terminals. Overall, we propose that in FCD tissue, the clusters of increased interneuron terminals impinging on glutamatergic neurons along with a loss in release control by GABA B receptors leads to an abnormally large release of GABA, leading to pathologically increased synchronization, presumably due to Cl ± in¯ux-dependent, KCC2-driven K + accumulation. In addition, since ictal discharges are abolished by NMDA receptor antagonists and since an abnormal distribution of NMDA receptors has been reported in human FCD tissue, ictal synchronization appears to depend on this glutamatergic mechanism.
